Ophthalmology Doctors in Southaven, MS Accepting Medicare

4 Ophthalmology doctors found. Showing 1 - 4

Michael L Wertheimer, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 726 Goodman Rd E # B, Southaven, MS 38671 Phone: 662-349-1959    Fax: 662-349-0424

Dr. Jorge I Calzada, M.D. Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 7900 Airways Blvd Bldg A1, Southaven, MS 38671 Phone: 417-889-2040    Fax: 417-889-2041

Dr. Alan R Schaeffer, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 726 Goodman Rd E, # B, Southaven, MS 38671 Phone: 662-349-1959    Fax: 662-349-0424

Mrs. Rashmi K Pandya-lipman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3964 Goodman Rd E Ste 125, Southaven, MS 38672 Phone: 662-890-7361    Fax: 662-890-7369

News Archive

Warnings on stop smoking drug Champix

The smoking cessation drug Champix (sold in the US as Chantix) has allegedly made fifteen people commit suicide since January 2008 in Australia. Another 191 patients have reported suicidal thoughts and related effects. The latest available figures from the Therapeutic Goods Administration (TGA) suggest a doubling in the numbers of suicides linked to Champix (Varenicline) since July last year with six people committing suicide.

FDA approves Codman's MEDSTREAM Programmable Infusion System

Codman & Shurtleff, Inc. (Codman), the global neurological device company, has received U.S. Food and Drug Administration (FDA) approval through a PMA supplement for its MEDSTREAM Programmable Infusion System, an implantable infusion pump and catheter system used in the treatment of spasticity, a movement disorder often caused by stroke, cerebral palsy, multiple sclerosis or spinal cord injury.

MonoSol Rx receives positive FDA feedback on 505(b)(2) pathway for Montelukast Sodium OSF

MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it held a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of Montelukast Sodium Oral Soluble Film (OSF) under a 505(b)(2) pathway.

Genetic diversity impacts efficacy of cancer immunotherapy

The constant battle against infectious pathogens has had a decisive influence on the human immune system over the course of our evolution.

South African mines must have HIV, TB, workplace safety policies to receive license, Minister says

Speaking at an event where South African Deputy President Kgalema Motlanthe urged the mining industry to take greater steps to address tuberculosis (TB) and HIV among its employees, Mineral Resources Minister Susan Shabangu "announced that mining companies, whose HIV, TB and workplace safety policies are being audited by her department, will have to submit their policies as a prerequisite for renewing their mining licenses," PlusNews reports.

Read more Medical News

› Verified 6 days ago